NutriBand Shareholders OK Doubling Authorized Shares
Ticker: NTRBW · Form: 8-K · Filed: Jan 25, 2024 · CIK: 1676047
Complexity: simple
Sentiment: mixed
Topics: shareholder-vote, corporate-governance, capital-structure, dilution-risk
TL;DR
**NutriBand just doubled its authorized shares, giving them room to raise cash but potentially diluting current stock.**
AI Summary
NutriBand Inc. filed an 8-K on January 25, 2024, reporting that on January 21, 2024, its shareholders voted to approve an amendment to the company's certificate of incorporation. This amendment increases the authorized shares of common stock from 50,000,000 to 100,000,000 and the authorized shares of preferred stock from 5,000,000 to 10,000,000. This matters to investors because it gives NutriBand the flexibility to raise more capital or make acquisitions by issuing new shares, which could dilute the value of existing shares if not used strategically.
Why It Matters
This vote allows NutriBand to issue significantly more stock, potentially raising capital for growth or acquisitions, but also risking dilution for current shareholders.
Risk Assessment
Risk Level: medium — Increasing authorized shares creates potential for dilution if new shares are issued, which could negatively impact existing shareholders' ownership percentage and share value.
Analyst Insight
A smart investor would monitor future filings for any announcements regarding new share issuances or capital raises, as these could impact share price and ownership percentage. Evaluate the company's strategic use of this increased flexibility.
Key Numbers
- 100,000,000 — New Authorized Common Stock (Doubled from 50,000,000, providing more shares for potential issuance.)
- 10,000,000 — New Authorized Preferred Stock (Doubled from 5,000,000, offering flexibility for different types of capital raises.)
Key Players & Entities
- NutriBand Inc. (company) — the registrant filing the 8-K
- January 21, 2024 (date) — date of the shareholder vote
- January 25, 2024 (date) — date the 8-K was filed
- 50,000,000 (dollar_amount) — previous authorized common stock
- 100,000,000 (dollar_amount) — new authorized common stock
- 5,000,000 (dollar_amount) — previous authorized preferred stock
- 10,000,000 (dollar_amount) — new authorized preferred stock
Forward-Looking Statements
- NutriBand will utilize the increased authorized shares to raise capital within the next 12-18 months. (NutriBand Inc.) — medium confidence, target: 2025-07-25
- The company may use the additional shares for strategic acquisitions. (NutriBand Inc.) — medium confidence, target: 2026-01-25
FAQ
What was the primary purpose of the shareholder vote reported in this 8-K?
The primary purpose was to approve an amendment to NutriBand Inc.'s certificate of incorporation to increase the number of authorized shares of common stock and preferred stock, as reported on January 21, 2024.
By how much did the authorized common stock increase?
The authorized common stock increased from 50,000,000 shares to 100,000,000 shares, effectively doubling the previous amount.
What was the change in authorized preferred stock?
The authorized preferred stock increased from 5,000,000 shares to 10,000,000 shares, also doubling the previous amount.
When did the event reported in this 8-K occur?
The earliest event reported, the shareholder vote, occurred on January 21, 2024.
What is the potential impact of this increase in authorized shares on existing shareholders?
The potential impact is dilution of existing shareholders' ownership percentage and value per share if NutriBand Inc. issues a significant number of these new shares in the future.
Filing Stats: 687 words · 3 min read · ~2 pages · Grade level 13.6 · Accepted 2024-01-25 16:40:43
Filing Documents
- ea192207-8k_nutriband.htm (8-K) — 54KB
- 0001213900-24-006496.txt ( ) — 264KB
- ntrb-20240121.xsd (EX-101.SCH) — 3KB
- ntrb-20240121_def.xml (EX-101.DEF) — 26KB
- ntrb-20240121_lab.xml (EX-101.LAB) — 36KB
- ntrb-20240121_pre.xml (EX-101.PRE) — 25KB
- ea192207-8k_nutriband_htm.xml (XML) — 5KB
07
Item 5.07 Submission of Matters to a Vote of Security Holders. The Company's 2023 Annual Meeting of Stockholders was held on January 21, 2024, in Orlando, Florida. At the meeting two proposals were on the agenda for approval by the Company's stockholders: election of six directors and ratification of the engagement of Sadler, Gibb & Associates, LLC as the Company's independent audit firm for fiscal 2023. In addition, the non-binding "say on pay" vote on approval of executive compensation and the "say on frequency" vote on the frequency of the say on pay vote were voted on by the stockholders. The results of the stockholder votes on each of these proposals is set forth below. At the 2023 Annual Meeting, the stockholders elected the six candidates nominated by the Company's Board of Directors to serve as directors for one-year terms, each until his or her successor is duly elected and qualified. The table below presents the results of the shareholder votes at the annual meeting on election of six directors, and of the votes as to ratification of the selection of the Company's audit firm for 2023, and the votes on "say on pay" on executive compensation and "say on frequency" of the shareholder say on pay votes.: Director Name Total Votes For Votes Withheld Votes Against Votes Abstain Broker Non- Vote Gareth Sheridan 5,299,587 46,785 - - 400,979 Serguei Melnik 5,282,321 64,051 - - 400,979 Mark Hamilton 5,235,220 111,152 - - 400,979 Radu Bujoreanu 5,248,479 97,893 - - 400,979 Stefani Mancas 5,303,429 42,943 - - 400,979 Irina Gram 5,253,489 92,883 - - 400,979 Proposal Total Votes For Votes Withheld Votes Against Votes Abstain Broker Non- Vote Ratify the Selection of Sadler, Gibb & Associates 5,720,198 27,097 56 - Advisory Approval of Executive Compensation 5,299,717 46,012 637 400,985 Advisory Approval on Frequency of Exec Comp - 1 Yr 5,319,922 - - 7,117 400,979 Advisory Approval on
SIGNATURES
SIGNATURES PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED. NUTRIBAND, INC. Date: January 25, 2024 By: /s/ Gareth Sheridan R: Gareth Sheridan Chief Executive Officer 2